'+
'| • '+heading+' |
| '+
''+
' |
'); } function hiLite(imgDocID,imgObjName) { document.images[imgDocID].src = eval(imgObjName + ".src"); } function showStatus(toshow) { window.status = toshow; } function checkChoose() { if (document.choose.ticker.value == "") { alert("Please enter symbols before clicking the go button"); return false; } else return true; } function popJT(url,name){ var xwid = screen.width; xwid = xwid - 10; javaticker = window.open(url,name,'width='+xwid+',height=100,resizable=yes,scrollbars=no,toolbar=no,location=no,directories=no,status=yes,menubar=no'); javaticker.opener.name="opener"; //javaticker.moveTo(0,30); } var allow = 0; var ref = ""+location; if ((ref.indexOf("cryptocurrencieschannel.com") > 0) || (ref.indexOf("cefchannel.com") > 0) || (ref.indexOf("bdcinvestor.com") > 0) || (ref.indexOf("tickertech.com") > 0) || (ref.indexOf("xxxx:") > 0) || (ref.indexOf("javascript:") > 0) || (ref.indexOf("filseclab.com") > 0) || (ref.indexOf("msnscache.com") > 0) || (ref.indexOf("toolbar.google.com") > 0) || (ref.indexOf("etfchannel.com") > 0) || (ref.indexOf("marketnewsvideo.com") > 0) || (ref.indexOf("news.google.com") > 0) || (ref.indexOf("dividendchannel.com") > 0) || (ref.indexOf("www.google.com") > 0) || (ref.indexOf("energystockchannel.com") > 0) || (ref.indexOf("metalschannel.com") > 0) || (ref.indexOf("portfoliochannel.com") > 0) || (ref.indexOf("canadastockchannel.com") > 0) || (ref.indexOf("theonlineinvestor.com") > 0) || (ref.indexOf("investhelp.com") > 0) || (ref.indexOf("preferredstockchannel.com") > 0) || (ref.indexOf("stockoptionschannel.com") > 0) || (ref.indexOf("holdingschannel.com") > 0) || (ref.indexOf("tickertech.net") > 0) || (ref.indexOf("historicalstockprice.com") > 0) || (ref.indexOf("splithistory.com") > 0) || (ref.indexOf("stocksplithistory.com") > 0) || (ref.indexOf("google.c") > 0) || (ref.indexOf("208.71.46.190") > 0) || (ref.indexOf("search.yahoo") > 0) || (ref.indexOf("sharesoutstandinghistory.com") > 0) || (ref.indexOf("marketcaphistory.com") > 0) || (ref.indexOf("ytdreturn.com") > 0) || (ref.indexOf("averageannualreturn.com") > 0) || (ref.indexOf("redinews.com") > 0) || (ref.indexOf("technicalanalysischannel.com") > 0) || (ref.indexOf("stockdma.com") > 0) || (ref.indexOf("stockrsi.com") > 0) || (ref.indexOf("stockmacd.com") > 0) || (ref.indexOf("topdividends.com") > 0) || (ref.indexOf("monthlydividendpayingstocks.com") > 0) || (ref.indexOf("nextearningsdate.com") > 0) || (ref.indexOf("pastearnings.com") > 0) || (ref.indexOf("historicalperatio.com") > 0) || (ref.indexOf("historicalearnings.com") > 0) || (ref.indexOf("webcache.googleusercontent.com") > 0)) { allow = 1; } function ShowTTIPage() { if (allow) { document.write('\n'); } if (allow) { document.write('
\n'); } if (allow) { document.write('| 4/11 - 7:00 AM \; \; | \n'); } if (allow) { document.write('Castle Biosciences to Release First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 2, 2024 | \n'); } if (allow) { document.write('
| 4/10 - 5:00 PM \; \; | \n'); } if (allow) { document.write('Castle Biosciences Celebrates Esophageal Cancer Awareness Month through Advocacy and Educational Collaborations | \n'); } if (allow) { document.write('
| 4/10 - 7:00 AM \; \; | \n'); } if (allow) { document.write('Castle Biosciences\' Chief Financial Officer Frank Stokes Recognized as a Top CFO of Houston for Second Consecutive Year | \n'); } if (allow) { document.write('
| 4/4 - 4:30 PM \; \; | \n'); } if (allow) { document.write('Presentations at EADO Highlight Potential Impact of Castle Biosciences\' DecisionDx-Melanoma and DecisionDx-SCC Tests on the Management of Patients with Skin Cancer | \n'); } if (allow) { document.write('
| 4/2 - 7:00 AM \; \; | \n'); } if (allow) { document.write('Castle Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference | \n'); } if (allow) { document.write('
| 3/27 - 5:00 PM \; \; | \n'); } if (allow) { document.write('Castle Biosciences Announces Updates to its Board of Directors | \n'); } if (allow) { document.write('
| 3/25 - 7:00 AM \; \; | \n'); } if (allow) { document.write('Castle Biosciences Earns a Top Workplaces USA Award for the Third Consecutive Year | \n'); } if (allow) { document.write('
| 3/22 - 4:30 PM \; \; | \n'); } if (allow) { document.write('Long-term Outcomes Data Shared at SSO 2024 Show That Patients with a Low-Risk DecisionDx-Melanoma Test Result Were Recurrence Free at Three Years, Including Those Who Utilized the Test to Help Guide the Decision to Avoid an SLNB | \n'); } if (allow) { document.write('
| 3/19 - 7:00 AM \; \; | \n'); } if (allow) { document.write('Leading Squamous Cell Carcinoma Practitioners Publish Consensus Guidelines Integrating DecisionDx-SCC into a Clinical Workflow to Improve Decision-Making Regarding the Use of Adjuvant Radiation Therapy | \n'); } if (allow) { document.write('
| 3/15 - 4:30 PM \; \; | \n'); } if (allow) { document.write('New Study Shows that the Drug-Drug Interactions and Lifestyle Factors Provided by Castle Biosciences\' IDgenetix Test Significantly Improve Medication Recommendations Over Drug-Gene Interactions Alone for Patients 65 and Older | \n'); } if (allow) { document.write('
| 3/12 - 7:00 AM \; \; | \n'); } if (allow) { document.write('Castle Biosciences to Present at the KeyBanc Capital Markets Virtual Life Sciences &\; MedTech Investor Forum | \n'); } if (allow) { document.write('
| 3/8 - 4:30 PM \; \; | \n'); } if (allow) { document.write('Castle Biosciences to Present New Data Highlighting the Clinical Value of its Dermatologic Tests for Patients with Skin Cancer at the 2024 American Academy of Dermatology (AAD) Annual Meeting | \n'); } if (allow) { document.write('
| 3/7 - 7:00 AM \; \; | \n'); } if (allow) { document.write('In Novel Cohort, New Data Confirms DecisionDx-SCC Provides Significant, Independent and Clinically Actionable Risk-Stratification of Patients, Including in Various High-Risk Subgroups | \n'); } if (allow) { document.write('
| 2/29 - 11:56 AM \; \; | \n'); } if (allow) { document.write('Thursday Sector Laggards: Medical Instruments & Supplies, Diagnostics [VIDEO] | \n'); }
if (allow) { document.write('
| 2/28 - 4:05 PM \; \; | \n'); } if (allow) { document.write('Castle Biosciences Reports Fourth Quarter and Full-Year 2023 Results | \n'); } if (allow) { document.write('
| 2/26 - 7:00 AM \; \; | \n'); } if (allow) { document.write('Study Finds DecisionDx-Melanoma Significantly Improves the Risk Stratification of Patients with Stage I Melanoma Compared to American Joint Committee on Cancer 8th Edition Staging | \n'); } if (allow) { document.write('
| 2/7 - 7:00 AM \; \; | \n'); } if (allow) { document.write('Castle Biosciences to Release Fourth Quarter and Full-Year 2023 Financial Results and Host Conference Call on Wednesday, Feb. 28, 2024 | \n'); } if (allow) { document.write('
| 1/18 - 7:00 AM \; \; | \n'); } if (allow) { document.write('New Study Highlights Significant Potential Medicare Savings Through Use of Castle Biosciences\' DecisionDx-SCC Test to Guide Adjuvant Radiation Therapy Decisions in Patients with Cutaneous Squamous Cell Carcinoma | \n'); } if (allow) { document.write('
| 1/14 - 4:30 AM \; \; | \n'); } if (allow) { document.write('Castle Biosciences Presents Data Supporting the Utility of Its Tests in the Clinical Care of Patients with Skin Cancers at the 2024 Winter Clinical Dermatology Conference - Hawaii | \n'); } if (allow) { document.write('
| 1/9 - 7:00 AM \; \; | \n'); } if (allow) { document.write('Castle Biosciences\' Chief Operating Officer Kristen Oelschlager Selected Among the Top 25 Women Leaders in Biotechnology by The Healthcare Technology Report | \n'); } if (allow) { document.write('
 | |
| more news | \n'); } if (allow) { document.write('\n'); } if (allow) { document.write(' |
If you reached this page'+
' after attempting to place a TickerTech.com product onto your web page, go no further; you must sign up as a'+
' paying client. For pricing information please visit our products page, email '+
' services@tickertech.com, or give us a call at 1-866-515-2082.'+
' '+
'